![]() |
|
|
Vol. 298, Issue 1, 197-200, July 2001
Laboratory of Nutritional Chemoprevention in Digestive Oncology
(S.C., Y.S., B.D., F.G., N.S., F.R.) and Laboratory of Molecular
Oncology (J.C.), Institut de Recherche contre les Cancers de
l'Appareil Digestif (IRCAD), Strasbourg, France
Geraniol and other monoterpenes found in essential oils of fruits and
herbs have been suggested to represent a new class of agents for cancer
chemoprevention. As a first step in clarifying the mode of action of
geraniol on colon carcinogenesis, we studied its effects on the growth
of a human colon cancer cell line (Caco-2). Geraniol (400 µM) caused
a 70% inhibition of cell growth, with cells accumulating in the S
transition phase of the cell cycle, and concomitant inhibition of DNA
synthesis. No signs of cytotoxicity or apoptosis were detected.
Geraniol caused a 50% decrease of ornithine decarboxylase activity, a
key enzyme of polyamine biosynthesis, which is enhanced in cancer
growth. This led to a 40% reduction of the intracellular pool of
putrescine. Geraniol also activated the intracellular catabolism of
polyamines, indicated by enhanced polyamine acetylation. These
observations indicate that polyamine metabolism is presumably a target
in the antiproliferative properties of geraniol.
This article has been cited by other articles:
![]() |
D. A. Wiseman, S. R. Werner, and P. L. Crowell Cell Cycle Arrest by the Isoprenoids Perillyl Alcohol, Geraniol, and Farnesol Is Mediated by p21Cip1 and p27Kip1 in Human Pancreatic Adenocarcinoma Cells J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 1163 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Ong, R. Heidor, A. de Conti, M. L. Z. Dagli, and F. S. Moreno Farnesol and geraniol chemopreventive activities during the initial phases of hepatocarcinogenesis involve similar actions on cell proliferation and DNA damage, but distinct actions on apoptosis, plasma cholesterol and HMGCoA reductase Carcinogenesis, June 1, 2006; 27(6): 1194 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Oxenham, K. P. Svoboda, and D. R. Walters Altered growth and polyamine catabolism following exposure of the chocolate spot pathogen Botrytis fabae to the essential oil of Ocimum basilicum Mycologia, May 1, 2005; 97(3): 576 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Mo and C. E. Elson Studies of the Isoprenoid-Mediated Inhibition of Mevalonate Synthesis Applied to Cancer Chemotherapy and Chemoprevention Experimental Biology and Medicine, July 1, 2004; 229(7): 567 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Carnesecchi, A. Bradaia, B. Fischer, D. Coelho, M. Scholler-Guinard, F. Gosse, and F. Raul Perturbation by Geraniol of Cell Membrane Permeability and Signal Transduction Pathways in Human Colon Cancer Cells J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 711 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Carnesecchi, K. Langley, F. Exinger, F. Gosse, and F. Raul Geraniol, a Component of Plant Essential Oils, Sensitizes Human Colonic Cancer Cells to 5-Fluorouracil Treatment J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 625 - 630. [Abstract] [Full Text] [PDF] |
||||